A National Study Of Community Attitudes Toward Pharmaceutical Companies

WL
WIT Legal

Contributor

WIT is the only expert witness agency representing the world's top consulting and testifying experts. By anticipating major trends in litigation, WIT proactively builds teams consisting of academic and industry experts who have the credentials and experience to address our client's needs.
WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings.

WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. The survey, designed to provide a holistic understanding of public sentiment, sought to answer questions regarding how people today viewed the pharmaceutical industry in the wake of factors polarizing our national discourse.

More than 2,000 respondents from across the United States completed the survey, which included a wide range of questions regarding their:

  • Basic demographics
  • Personal experiences with COVID-19 and the opioid epidemic
  • Opinions of domestic and foreign pharmaceutical companies
  • Issues driving attitudes about the pharmaceutical industry.
  • And more

To view the full article, click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More